Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Doreen Braun
Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid Effects of Tyrosine Kinase Inhibitors
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor
Cureus
The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
Oncology
Hematology
Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Expressing P190BCR-Abl.
Internal Medicine
Internal Medicine
Medicine
Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
Oncology
Hematology
Philadelphia Chromosome‐negative Acute Leukemia in Chronic Myeloid Leukemia
American Journal of Hematology
Hematology
Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase
Revista de Chimie
Surfaces
Materials Science
Engineering
Materials Chemistry
Films
Coatings
Chemistry
Philadelphia Chromosome-Positive Acute Myelocytic Leukemia With French-American-British M2 Morphology, Refractory to Tyrosine Kinase Inhibitors
Tenri Medical Bulletin